NO

NovoCure

NASDAQ: NVCR

2 known investors

novocure.com ↗

Novocure is a global oncology company developing Tumor Treating Fields therapies, including its Optune Pax device, to treat aggressive cancers such as locally advanced pancreatic cancer. It serves cancer patients and their treating physicians in the medical device and healthcare sector.

Investors · 2

PF

Pfizer Venture Investments$5M – $20M

WI

Windham Capital PartnersNew York · $1M – $5M

Competitors · 1

by search overlap

ON

Onkure Therapeutics Inc41 shared keywordsOnKure Therapeutics is a clinical-stage biopharmaceutical company developing PI3Kα pan-mutant selective inhibitor medicines for the treatment of breast cancer and vascular anomalies. Its focus is on selective, allosteric small-molecule oncology therapeutics.

Companies competing with NovoCure for the same Google search keywords, organic and paid, via search-intersection analysis.